FatigFix™- a New Adaptogenic Ingredient for the Relief of Fatigue and

Improvement of Sleep Quality

Chrysalis Health & Beauty Business Solutions Limited have announced the launch of FatigFix™, a
new clinically proven formula to help reduce symptoms of fatigue and promote improvements in
sleep quality. The marketing of Fatigfix™ is a collaboration between the technology holder
Phynova Group Limited and Chrysalis Health & Beauty who jointly seek distributors for Fatigfix™
globally.

Nottingham, United Kingdom, November 29, 2010 --(PR.com)-- Fatigfix™ is a safe and effective
solution for a problem effecting millions of people worldwide. FatigFix™ has been shown in
double-blind, placebo-controlled studies of middle aged individuals complaining of fatigue symptoms, to
significantly reduce various symptoms of fatigue (lethargy, clarity of thought, frequency of headaches
etc.), increase energy levels, and improve the quality of sleep after only a few weeks of taking the
product. FatigFix™ is being offered as a functional health food ingredient and can be formulated into
various dosage forms including tablets/capsules, stick-pack, and drinks.

Chrysalis Director Mark Broughton commented, “FatigFix™ works as an 'adaptogenic formula' our
clinical studies demonstrate not only a reduction in day time fatigue, but also a significant improvement
in sleep patterns and quality of sleep.” FatigFix™ is a novel combination of three highly effective plant
extracts, each with a well-established history of safe use as adaptogens.

Phynova is seeking to commercialise FatigFix™ in the USA, Far East, Middle East and Africa, Latin
America, and some European countries. Enquiries should be made to Phynova's marketing partners
Chrysalis Health & Beauty Business Solutions Limited for details of available markets for the active
ingredient and finished product formats.

About Phynova Group Limited: Phynova is a UK company developing prescription pharmaceuticals,

OTC drugs (Traditional Medicinal Herbal Products) and functional ingredients for healthcare and
personal care markets, that are derived from plants used in Chinese medicines. Phynova specializes in
gastroenterology (including hepatology), metabolic disorders and anti-infectives. Phynova's lead product
for postoperative ileus is currently enrolling patients in a Phase II proof-of-concept clinical trial in China.
Other products include a candidate for the symptoms of chronic hepatitis C, which has completed a Phase
I/II trial in the US and a Phase II trial in the UK; and two further products, a topic antibacterial for MRSA
and a treatment for obesity and non-alcoholic fatty liver disease, are targeted for entry to the clinic over
the upcoming two years. For further information please visit www.phynova.com

About Chrysalis Health & Beauty Business Solutions Limited. Chrysalis Health & Beauty is a UK
company specialist in the sales and marketing of innovative ingredients and products for Pharma,
nutraceutical and personal care sectors. For further information please visit www.fatigfix.com/ or contact
info@chrysalisweb.com

www.fatigfix.com

Page 1/3
PR.com Press Release Distribution Terms of Use
###

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
Chrysalis Health & Beauty Business Solutions Limited
Mark Broughton
+44 115 9771054
info@chrysalisweb.com
www.chrysalisweb.com

Online Version of Press Release:

You can read the online version of this press release at: http://www.pr.com/press-release/280169

Page 3/3
PR.com Press Release Distribution Terms of Use